Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Koppers Holdings (KOP) Asset Writedowns and Impairment (2016 - 2017)

Koppers Holdings' Asset Writedowns and Impairment history spans 5 years, with the latest figure at $3.7 million for Q4 2017.

  • For Q4 2017, Asset Writedowns and Impairment changed N/A year-over-year to $3.7 million; the TTM value through Dec 2017 reached $14.8 million, up 18.4%, while the annual FY2017 figure was $3.7 million, 5.71% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2017 was $3.7 million at Koppers Holdings, up from $3.5 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $7.6 million in Q4 2015 and bottomed at $1.4 million in Q3 2015.
  • The 5-year median for Asset Writedowns and Impairment is $3.6 million (2016), against an average of $4.2 million.
  • The largest annual shift saw Asset Writedowns and Impairment fell 29.79% in 2015 before it skyrocketed 150.0% in 2016.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $6.9 million in 2013, then crashed by 31.88% to $4.7 million in 2014, then soared by 61.7% to $7.6 million in 2015, then tumbled by 53.95% to $3.5 million in 2016, then grew by 5.71% to $3.7 million in 2017.
  • Per Business Quant, the three most recent readings for KOP's Asset Writedowns and Impairment are $3.7 million (Q4 2017), $3.5 million (Q3 2016), and $7.6 million (Q4 2015).